cyclopentenone has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bramanti, P; Cuzzocrea, S; Di Paola, R; Esposito, E; Genovese, T; Mazzon, E; Meli, R; MuiĆ , C | 1 |
Furuta, K; Hatanaka, H; Ishikawa, Y; Nakatsuka, D; Namura, S; Satoh, T; Sugie, Y; Suzuki, M; Tomokiyo, K; Watanabe, Y | 1 |
Britti, D; Caputi, AP; Chatterjee, PK; Cuzzocrea, S; Di Paola, R; Dugo, L; Mazzon, E; Serraino, I; Thiemermann, C; Wayman, NS | 1 |
3 other study(ies) available for cyclopentenone and Disease Models, Animal
Article | Year |
---|---|
Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
Topics: Animals; Cyclization; Cyclopentanes; Disease Models, Animal; Inflammation Mediators; Ligands; Male; Mice; Mice, Inbred Strains; Neutrophil Infiltration; Peroxisome Proliferator-Activated Receptors; PPAR gamma; Prostaglandin D2; Random Allocation; Recovery of Function; Severity of Illness Index; Spinal Cord Injuries | 2008 |
Neurotrophic actions of novel compounds designed from cyclopentenone prostaglandins.
Topics: Animals; Biotin; Brain Ischemia; Cell Survival; Cells, Cultured; Cyclopentanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Mice; Microinjections; Nerve Growth Factors; Neurites; Neurons; Neuroprotective Agents; Prostaglandin D2; Prostaglandins; Structure-Activity Relationship | 2001 |
The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation.
Topics: Animals; Arthritis, Experimental; Carrageenan; Cyclopentanes; Disease Models, Animal; Immunohistochemistry; Immunologic Factors; Inflammation; Male; Mice; Mice, Inbred BALB C; Pleurisy; Prostaglandin D2 | 2002 |